Stephen Sonis, DMD, DMSc
 Stephen T. Sonis, DMD, DMSc Dr. Sonis is a Professor of Oral Medicine at Harvard, Senior Surgeon at Brigham and Women’s Hospital and a designated member of the Distinguished Faculty at the Dana-Farber Cancer Institute. In addition to his academic appointments, Dr. Sonis is a co-founder and Chief Scientific Officer (CSO) of Biomodels, LLC and Primary Endpoint Solutions, LLC; Past president of TRIAD, an international not-for-profit focused on the adverse health and economic outcomes of cancer toxicities; and a special government employee of the FDA. He has published extensively on the clinical, biological, and health economic aspects of cancer and complications associated with its treatment. He holds several patents and is the author of more than 250 original publications, reviews, and chapters and is completing his eleventh book. After receiving his DMD from Tufts, Dr. Sonis completed a combined doctorate and residency at Harvard and was a Knox Fellow at Oxford.
|
